Core Wealth Advisors (Florida)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Core Wealth Advisors (Florida)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,078	Closed	-$95K	–	216
2022 Q1	$95K	Buy	2,078 +232	+13%	+$11.1K	0.05%	56
2021 Q4	$113K	Buy	1,846 +211	+13%	+$14.6K	0.07%	55
2021 Q3	$122K	Buy	1,635 +117	+8%	+$9.82K	0.08%	55
2021 Q2	$140K	Sell	1,518 -1,013	-40%	-$86.1K	0.09%	44
2021 Q1	$225K	Buy	2,531 +1,013	+67%	+$100K	0.2%	30
2020 Q4	$142K	Buy	1,518 +43	+3%	+$3.43K	0.13%	34
2020 Q3	$94K	Hold	1,475	–	–	0.09%	39
2020 Q2	$77K	Buy	+1,475	New	+$63.3K	0.07%	48

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Core Wealth Advisors (Florida)'s ARKG Position: Q2 2022 in Review

Core Wealth Advisors (Florida) sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 2,078 shares — an estimated $95K sold.

Core Wealth Advisors (Florida) first reported a position in ARKG in Q2 2020 and held it in 8 quarters. The position peaked at $225K in Q1 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Core Wealth Advisors (Florida) reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Core Wealth Advisors (Florida) sold 2,078 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $95K.
Core Wealth Advisors (Florida) first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 8 quarters.
Core Wealth Advisors (Florida)'s ARK Genomic Revolution ETF position peaked at $225K in Q1 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Core Wealth Advisors (Florida)'s 13F filing for Q2 2022, filed 12 Aug 2022.